Early Access

10-QPeriod: Q1 FY2025

Philip Morris International Inc. Quarterly Report for Q1 Ended Mar 31, 2025

Filed April 24, 2025For Securities:PM

Summary

Philip Morris International Inc. (PMI) reported a strong first quarter for 2025, with net revenues increasing by 5.8% to $9.3 billion and diluted EPS rising by 24.6% to $1.72. This growth was driven by a favorable pricing variance, particularly in combustible tobacco, and robust volume/mix improvements, largely attributed to strong performance in smoke-free products (SFPs). The company's strategic shift towards a smoke-free future continues to gain momentum, with SFPs representing a growing portion of net revenues. PMI's operational income saw a significant increase of 16.4%, benefiting from favorable pricing and volume/mix, as well as a lower effective tax rate and reduced interest expenses. The company's proactive management of its financial structure and ongoing investment in its smoke-free portfolio position it well for continued growth and transformation. The company's smoke-free products business demonstrated impressive growth, with total smoke-free net revenues up 15.0% year-over-year, driven by broad-based strength across all SFP categories, especially in the Americas and Europe. Oral smoke-free product volumes, including ZYN nicotine pouches, saw a substantial 31.0% increase. PMI's commitment to innovation and scientific substantiation for its SFPs continues to underpin its market position and regulatory approvals, such as the recent FDA authorization for multiple ZYN nicotine pouch varieties. Despite a challenging operating environment with inflationary pressures and evolving regulations, PMI's diversified geographic presence and ongoing strategic execution suggest resilience and a positive outlook for its transition to a smoke-free future.

Financial Statements
Beta

Key Highlights

  • 1Net revenues increased 5.8% to $9.3 billion, driven by favorable pricing and strong smoke-free product performance.
  • 2Diluted Earnings Per Share (EPS) grew 24.6% to $1.72, outperforming the prior year.
  • 3Operating income increased by 16.4% to $3.54 billion, reflecting improved pricing, volume/mix, and operational efficiencies.
  • 4Smoke-free product net revenues increased by 15.0%, demonstrating continued strong growth in this strategic category.
  • 5Oral smoke-free product volume (including ZYN nicotine pouches) surged by 31.0%, highlighting the success of the Swedish Match acquisition.
  • 6The company's effective tax rate decreased to 20.0%, contributing positively to net earnings.
  • 7Total shipment volume increased by 3.9%, with smoke-free products up 14.4%.

Frequently Asked Questions